...
首页> 外文期刊>Acta endocrinologica >Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values
【24h】

Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values

机译:脑外伤后垂体功能减退:使用不同的动态测试和不同的正常值会影响患病率

获取原文
           

摘要

Objective Traumatic brain injury (TBI) has emerged as an important cause of hypopituitarism. However, considerable variations in the prevalence of hypopituitarism are reported. These can partly be explained by severity of trauma and timing of hormonal evaluation, but may also be dependent on endocrine tests and criteria used for diagnosis of hypopituitarism. Methods Systematic review of studies reporting prevalence of hypopituitarism in adults ≥1 year after TBI focusing on used (dynamic) tests and biochemical criteria. Results We included data from 14 studies with a total of 931 patients. There was considerable variation in definition of hypopituitarism. Overall, reported prevalences of severe GH deficiency varied between 2 and 39%. Prevalences were 8–20% using the GHRH–arginine test (cutoff 9 μg/l), 11–39% using the glucagon test (cutoff 1–5 μg/l), 2% using the GHRH test (no cutoff), and 15–18% using the insulin tolerance test (ITT; cutoff 3 μg/l). Overall, the reported prevalence of secondary adrenal insufficiency had a broad range from 0 to 60%. This prevalence was 0–60% with basal cortisol (cutoff 220 or 440 nmol/l), 7–19% using the ACTH test, and 5% with the ITT as first test (cutoff 500 or 550 nmol/l). Secondary hypothyroidism was present in 0–19% (free thyroxine) or 5–15% (thyroid-releasing hormone stimulation). Secondary hypogonadism was present in 0–29%. Conclusion The reported variations in the prevalence rates of hypopituitarism after TBI are in part caused by differences in definitions, endocrine assessments of hypopituitarism, and confounding factors. These methodological issues prohibit simple generalizations of results of original studies on TBI-associated hypopituitarism in the perspective of meta-analyses or reviews.
机译:目的外伤性脑损伤(TBI)已成为垂体功能低下的重要原因。但是,据报道垂体功能低下的患病率有很大差异。这些可以部分通过创伤的严重程度和激素评估的时间来解释,但也可能取决于内分泌检查和垂体功能低下诊断标准。方法系统回顾性研究报告了TBI≥1年的成年人中垂体功能低下的患病率,研究重点是二手(动态)测试和生化指标。结果我们纳入了来自14项研究的数据,共931例患者。垂体功能低下的定义存在很大差异。总体而言,报告的严重GH缺乏症患病率在2%至39%之间。使用GHRH-精氨酸测试(临界值<9μg/ l)的发生率为8–20%,使用胰高血糖素测试(临界值1-5μg/ l)的发生率为11–39%,使用GHRH测试(无临界值)的发生率为2%,使用胰岛素耐受性测试(ITT;截断值<3μg/ l)则为15–18%。总体而言,报告的继发性肾上腺皮质功能不全的患病率范围为0%至60%。基底皮质醇的发生率为0–60%(临界值<220或<440 nmol / l),使用ACTH试验的发生率为7–19%,ITT的首次试验为5%(临界值<500或<550 nmol / l) )。继发性甲状腺功能减退症的发生率为0–19%(游离甲状腺素)或5–15%(甲状腺释放激素刺激)。继发性腺功能减退的发生率为0-29%。结论报道的TBI后垂体功能低下患病率的变化部分是由于定义不同,垂体功能低下的内分泌评估和混杂因素引起的。这些方法论问题禁止从荟萃分析或综述的角度简单归纳与TBI相关的垂体机能减退症的原始研究结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号